Photodynamic therapy simultaneously induces ferroptosis- and apoptosis-like lipid signatures in ovarian cancer cells

Marta Overchuk & Imran Rizvi et al. · 2025-12-10

Abstract

Resistance to apoptosis-inducing chemotherapy is a major factor contributing to treatment failure and poor survival outcomes in high-grade serous ovarian cancer (HGSOC). Ferroptosis, a regulated form of cell death driven by lipid peroxidation, has emerged as a promising effector mechanism because it remains available in HGSOC cells with impaired apoptosis signaling. While most research has focused on pharmacological ferroptosis inducers, there is growing interest in strategies that could trigger lipid autoxidation through externally delivered energy, such as photons. Photodynamic therapy (PDT), which utilizes light and light-activatable photosensitizers to generate reactive molecular species, offers a means of initiating lipid peroxidation with a high degree of precision and minimal systemic toxicities. However, the precise lipid targets of PDT, the influence of varying tumor lipidomic landscapes, and the role of ferroptosis sensitivity on PDT-lipid interactions have yet to be elucidated. In this study, we systematically compare PDT to ferroptosis induced by the inhibition of glutathione peroxidase 4, focusing on lipid redox states and composition in HGSOC cell lines. While PDT was similarly effective in both ferroptosis-sensitive and -resistant cells, its effects on cellular lipidomes differed markedly. PDT robustly induced lipid radical formation in both cell types; however, a dose-dependent accumulation of lipid hydroxides and hydroperoxides was only observed in ferroptosis-sensitive cells rich in unsaturated phospholipids. Further analysis revealed a significant overlap in lipid oxidation targets between PDT and ferroptosis. Notably, in both cell types, and in vivo, PDT upregulated ceramides, a lipid class strongly associated with mitochondrial apoptosis. In summary, PDT exhibited comparable efficacy in both ferroptosis-sensitive and -resistant cells by triggering a combination of lipid peroxidation and ceramide upregulation, suggesting the activation of both ferroptosis and apoptosis pathways. Further studies are needed to explore the role of PDT-induced lipidomic changes in the initiation of various cell death pathways and in overcoming chemoresistance in HGSOC.

Funding
Integrating tumor and stroma to understand and predict treatment responseIntegrating tumor and stroma to understand and predict treatment responseCAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)Pre- and Postdoctoral Training in ToxicologyTargeting Fluid Stress-induced Chemoresistance in a 3D Carcinomatosis Perfusion Model Using Mechanism-based Photo-immunoconjugate NanoparticlesPhotodynamic Alteration of Cell Membrane Lipids to Enhance Chemotherapy Efficacy in Metastatic Ovarian CancerIron, NO, and Lipid Peroxide in Photodynamic TherapyU.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) Grant CA70823Targeting Fluid Stress-induced Chemoresistance in a 3D Carcinomatosis Perfusion Model Using Mechanism-based Photo-immunoconjugate NanoparticlesAdvancing functional mass spectrometry imaging methodology to monitor dynamic physiological processesPhotodynamic Alteration of Cell Membrane Lipids to Enhance Chemotherapy Efficacy in Metastatic Ovarian CancerAmerican Cancer Society (American Cancer Society, Inc.) Grant PF-24-1198205-01-ETAdvancing functional mass spectrometry imaging methodology to monitor dynamic physiological processesAddressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome

NCI NIH HHS

U01 CA274298

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)

U01CA274298

NCI NIH HHS

T32 CA196589

NIEHS NIH HHS

T32 ES007126

NCI NIH HHS

R01 CA256710

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)

K99CA300924

NCI NIH HHS

R01 CA070823

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)

R01CA256710

NCI NIH HHS

R01 CA288969

NCI NIH HHS

K99 CA300924

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)

R01CA288969

NCI NIH HHS

R01 CA260340